Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gun Ho Jang

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Cell Biology|August 9, 2024
INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1-mediated lysosomal exocytosisGolam T Saffi, Lydia To, Nicholas Kleine, et al.
Frontiers in Genetics|November 29, 2023
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)Jannat Pervin, Mohammad Asad, Shaolong Cao, et al.
JCO Clinical Cancer Informatics|May 10, 2019
Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal AdenocarcinomaVandana Sandhu, Knut Jorgen Labori, Ayelet Borgida, et al.
Plos One|October 12, 2022
Mitochondrial fitness and cancer riskAndrew V Kossenkov, Andrew Milcarek, Faiyaz Notta, et al.
Science Advances|November 23, 2022
Widespread hypertranscription in aggressive human cancersMatthew Zatzman, Fabio Fuligni, Ryan Ripsman, et al.
JCO Precision Oncology|February 1, 2022
Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast CancersJane Bayani, Elizabeth N Kornaga, Cheryl Crozier, et al.
Science Advances|May 8, 2021
NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4Pallavi Jain, Anna Dvorkin-Gheva, Erik Mollen, et al.
Nature Cancer|March 6, 2024
Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cellsTajinder Ubhi, Olga Zaslaver, Andrew T Quaile, et al.
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Journal of Clinical Pathology|September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Cell Biology|August 9, 2024
INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1-mediated lysosomal exocytosisGolam T Saffi, Lydia To, Nicholas Kleine, et al.
Frontiers in Genetics|November 29, 2023
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)Jannat Pervin, Mohammad Asad, Shaolong Cao, et al.
JCO Clinical Cancer Informatics|May 10, 2019
Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal AdenocarcinomaVandana Sandhu, Knut Jorgen Labori, Ayelet Borgida, et al.
Plos One|October 12, 2022
Mitochondrial fitness and cancer riskAndrew V Kossenkov, Andrew Milcarek, Faiyaz Notta, et al.
Science Advances|November 23, 2022
Widespread hypertranscription in aggressive human cancersMatthew Zatzman, Fabio Fuligni, Ryan Ripsman, et al.
JCO Precision Oncology|February 1, 2022
Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast CancersJane Bayani, Elizabeth N Kornaga, Cheryl Crozier, et al.
Science Advances|May 8, 2021
NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4Pallavi Jain, Anna Dvorkin-Gheva, Erik Mollen, et al.
Nature Cancer|March 6, 2024
Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cellsTajinder Ubhi, Olga Zaslaver, Andrew T Quaile, et al.
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Journal of Clinical Pathology|September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.
Pageof 7